UBS AM’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-135,804
Closed -$452K 2527
2023
Q4
$452K Hold
135,804
﹤0.01% 2350
2023
Q3
$508K Buy
135,804
+21,924
+19% +$82K ﹤0.01% 2291
2023
Q2
$779K Hold
113,880
﹤0.01% 2117
2023
Q1
$779K Buy
113,880
+8,906
+8% +$60.9K ﹤0.01% 2117
2022
Q4
$831K Buy
104,974
+48,472
+86% +$384K ﹤0.01% 1947
2022
Q3
$543K Sell
56,502
-6,377
-10% -$61.3K ﹤0.01% 2312
2022
Q2
$455K Sell
62,879
-16,032
-20% -$116K ﹤0.01% 2349
2022
Q1
$1.02M Hold
78,911
﹤0.01% 2128
2021
Q4
$1.26M Hold
78,911
﹤0.01% 2082
2021
Q3
$1.27M Hold
78,911
﹤0.01% 2039
2021
Q2
$1.09M Sell
78,911
-132,538
-63% -$1.83M ﹤0.01% 2158
2021
Q1
$3.09M Sell
211,449
-2,042,457
-91% -$29.8M ﹤0.01% 1567
2020
Q4
$39.2M Buy
2,253,906
+555,584
+33% +$9.66M 0.02% 665
2020
Q3
$31.1M Sell
1,698,322
-138,838
-8% -$2.55M 0.02% 646
2020
Q2
$32.8M Sell
1,837,160
-22,017
-1% -$393K 0.02% 600
2020
Q1
$30.2M Sell
1,859,177
-58,297
-3% -$946K 0.02% 586
2019
Q4
$34.5M Buy
1,917,474
+346,993
+22% +$6.25M 0.02% 631
2019
Q3
$31.8M Buy
1,570,481
+51,968
+3% +$1.05M 0.02% 649
2019
Q2
$33.6M Sell
1,518,513
-53,377
-3% -$1.18M 0.02% 634
2019
Q1
$21.4M Buy
1,571,890
+257,191
+20% +$3.51M 0.02% 727
2018
Q4
$11.9M Buy
1,314,699
+52,862
+4% +$478K 0.01% 824
2018
Q3
$20.8M Sell
1,261,837
-51,136
-4% -$844K 0.02% 743
2018
Q2
$18.4M Sell
1,312,973
-8,297
-0.6% -$116K 0.01% 792
2018
Q1
$14.6M Sell
1,321,270
-72,391
-5% -$800K 0.01% 827
2017
Q4
$12.3M Buy
1,393,661
+72,710
+6% +$640K 0.01% 866
2017
Q3
$17.6M Sell
1,320,951
-70,265
-5% -$938K 0.02% 756
2017
Q2
$20M Buy
1,391,216
+490,899
+55% +$7.04M 0.02% 743
2017
Q1
$19M Buy
900,317
+398,644
+79% +$8.43M 0.02% 729
2016
Q4
$14.1M Buy
501,673
+482,828
+2,562% +$13.6M 0.02% 788
2016
Q3
$504K Buy
+18,845
New +$504K ﹤0.01% 1976
2016
Q2
Sell
-9,567
Closed -$203K 2613
2016
Q1
$203K Sell
9,567
-1,932
-17% -$41K ﹤0.01% 2426
2015
Q4
$264K Buy
+11,499
New +$264K ﹤0.01% 2399